Maternal and offspring immediate and long-term health are affected by pregnancy weight gain and maternal weight. This study was designed to determine feasibility of: 1) recruiting a socio-economically and racially/ethnically diverse sample of pregnant women into a longitudinal observational study, including consenting the women for serial biologic specimen evaluations; 2) implementing comprehensive assessments (including biologic, anthropometric, behavioral, cognitive/psychosocial and socio-demographic, and cultural measures) at multiple time points over the study period, including collecting biologic specimens at planned and unplanned pregnancy delivery times; and 3) retaining the sample for one year into the postpartum period. Additionally, the study will provide preliminary data of associations among hypothesized predictors, mediators and moderators of pregnancy and post-partum maternal and infant weight trajectories. The study was conceptualized under a Biopsychosocial Model using a lifespan approach. Study protocol and baseline characteristics are described.
We sought to recruit a sample of 100 healthy women age 18–45 years, between 28–34 weeks gestation, with singleton pregnancies, enrolled in care prior to 17 weeks gestation. Women provide written consent for face-to-face (medical history, anthropometrics, biologic specimens), and paper-and-pencil assessments, at five time points: baseline (third trimester), delivery-associated, and 6-weeks, 3-months and 6-months postpartum. Additional telephone-based assessments (diet, physical activity and breastfeeding) administered baseline and three-months postpartum. Infant weights are collected until 1-year of life. We seek to retain 80% of participants at six-months postpartum and 80% of offspring at 12-months.
110 women were recruited. Sample characteristics include: mean age 28.3 years, BMI 25.7 kg/m2, and gestational age at baseline visit of 32.5 weeks. One-third of cohort was non-white, over a quarter were Latina, and almost a quarter were non-US born. The cohort majority was multigravida, had graduated high school and/or had higher levels of education, and worked outside the home.
Documentation of study feasibility and preliminary data for theory-driven hypothesis of maternal and child factors associated with weight trajectories will support future large scale longitudinal studies of risk and protective factors for maternal and child health. This research will also inform intervention targets facilitating healthy maternal and child weight.
Maternal weight before, during, and after pregnancy is of considerable public health importance given its impact on both immediate and long-term maternal and child health. The majority of women and thus their children are at weight-related health risk when considering: (1) two-thirds of American women are overweight or obese [
Maternal obesity is associated with increased risks of gestational diabetes, large for gestational age neonates, and childhood obesity [
Acting upon scientific literature on weight gain patterns before, during, and after pregnancy, and in the context of a life-stage framework [
In an effort to promote these guidelines, several randomized control trials have tested interventions to optimize gestational weight gain; however, such interventions have had limited effectiveness [
The general non-pregnant obesity and weight gain literature has broad comprehensive models for understanding weight and obesity. For example, there has been increased attention to the roles and interplay of reduced sleep [
Given inadequate literature in these and relevant areas, action items in the 2009 IOM report included a recommendation to conduct comprehensive studies that examine how dietary intake, physical activity, dieting practices, food insecurity and, more broadly, the social, cultural and environmental context affect gestational weight gain [
A lifespan approach to the Biopsychosocial Model [
To establish the feasibility of: 1) recruiting a socio-economically and racially/ethnically diverse sample of pregnant women into a longitudinal observational study, including consenting the women for serial biologic specimen evaluations; 2) implementing comprehensive assessments (including biologic, anthropometric, behavioral, cognitive/psychosocial and socio-demographic and cultural measures) at multiple time points over the study period, including collecting biologic specimens at planned and unplanned pregnancy delivery times; and 3) retaining the sample for one year into the postpartum period. Additionally, the study will provide preliminary data of associations among hypothesized predictors, mediators and moderators of pregnancy weight gain and postpartum weight loss and retention, in accordance with the multifactorial model shown in Figure
The Pregnancy and Postpartum Observational Determinants Study (PPODS) is a prospective cohort feasibility study approved by the University of Massachusetts Medical School Institutional Review Board human subjects committee. In accordance with the Lifespan Biopsychosocial Model used as the framework for this study, comprehensive assessments starting in pregnancy and continuing over the postpartum period include demographic, biologic including anthropometric, behavioral, cognitive/psychological and socio-cultural factors hypothesized to influence gestational weight gain (GWG), postpartum weight loss, and clinical outcomes of healthy women and their offspring. At present, study recruitment is complete and participant follow up and analyses are ongoing.
The study is being conducted at the ambulatory faculty and resident obstetrical practices at a large tertiary hospital in Central Massachusetts, UMass Memorial Medical Center (UMMMC), in Worcester, MA, where approximately 20 residents, 3 nurse practitioners, and 14 attending faculty obstetricians provide prenatal and postpartum care to ethnically and socioeconomically diverse women. These practices deliver ~1,600 of the ~4, 000 pregnancies that are admitted to UMMMC each year.
Eligibility criteria include: (1) age ≥18 or ≤ 45 years, (2) singleton gestation, (3) English speaking, (4) no history of pre-gestational or current gestational diabetes, (5) no evidence of alcohol or substance abuse, (6) not taking medications that affect weight (anti-hypertensives, hypoglycemics, steroids, second generation anti-psychotics, anti-epileptics and thyroid-related pharmaceuticals), (7) no evidence of HIV, hepatitis, autoimmune disease, eating disorder history, or bariatric surgery history, and (8) prenatal care initiated ≤ 16 weeks and 6 days gestational age. Age of inclusion was restricted as GWG recommendations are somewhat controversial in adolescents and general weight gain increases with advancing age. Multiple gestations were excluded due to differences in GWG recommendations for twins, triplets and higher order multiples. Non-English speaking subjects were excluded due to limited resources. Subjects with diabetes were ineligible due to high potentiality of receiving treatments that affect weight (i.e., selected medications, dietary interventions). Subjects with substance abuse history, with prescriptions for aforementioned medication groups and with disease states listed were excluded due to effects on weight, weight gain and diet and on potential compliance and reliability in the former population. Subjects had to have initiated care in early pregnancy so that weight measurements throughout pregnancy were available for analyses.
Identification of eligible women occurred proactively. Between 24–28 weeks gestation, obstetric providers at study practices carry out universal gestational diabetes screening in all gravidas without pre-gestational type 1 or type 2 diabetes mellitus with a 50 g glucose load followed by plasma glucose determination in the subsequent hour [
Women were assessed at baseline, at delivery, in the immediate in-patient postpartum period and then postpartum at 6 weeks, 3 months and 6 months. Assessments included demographic, biologic including anthropometric, behavioral, cognitive/psychological and sociocultural evaluations. See Table
*Baseline visit occurring in pregnancy at approximately 28–34 weeks gestation.
†Subset of subjects only.
‡Participation in biologic specimen component of study was optional.
✓
✓
Medical History ✓ Blood Pressure ✓ ✓ ✓ ✓ ✓ Urine for protein and glucose ✓ ✓ ✓ ✓ ✓ Height ✓ Prepregnancy Weight & BMI ✓ Skin Fold Thickness (SFT) ✓ ✓ ✓ ✓ ✓ Waist, Hip and Arm Circumferences ✓ ✓ ✓ ✓ ✓ Genetics (Maternal buccal swab, umbilical cord and blood, placenta, adipose tissue†)‡
✓
24 Hour Dietary and Physical Activity Recalls ✓ ✓ 3-Factor Eating Questionnaire R18-modified ✓ ✓ ✓ ✓ ✓ Food Craving Inventory ✓ ✓ ✓ ✓ ✓ Pregnancy and Physical Activity Questionnaire (PPAQ) (modified postpartum) ✓ ✓ ✓ ✓ ✓ Breastfeeding-Infant Feeding Surveys ✓ ✓ ✓ ✓ ✓ Pittsburgh Sleep Quality Index ✓ ✓ ✓ ✓
Spielberger Trait Anxiety Inventory ✓ ✓ ✓ ✓ ✓ Perceived Stress Scale ✓ ✓ ✓ ✓ ✓ Quality of Life SF-12 with RAND score ✓ ✓ ✓ ✓ ✓ Happiness Scale ✓ ✓ ✓ ✓ ✓ Edinburgh Postnatal Depression Scale ✓ ✓ ✓ ✓ ✓ Pregnancy & Weight Gain Attitude Scale (PWGAS), modified ✓
Weight gain advice and purposeful weight control attempts survey ✓ ✓ ✓ ✓ Social Support ✓ ✓ ✓ ✓ ✓ Life Events ✓ ✓ ✓ ✓ ✓
Maternal Blood ✓ ✓ ✓ ✓ ✓ ✓ Umbilical Cord Blood ✓ Placenta ✓ Umbilical Cord ✓ Adipose Tissue† (Subcutaneous & Omental) ✓ Magnetic Resonance Imaging†
✓ Mouthwash Buccal Epithelial Cells for DNA ✓ ✓
Maternal Weight ✓ ✓ ✓ ✓ ✓ ✓ Neonatal Weight & Length ✓ ✓ ✓ ✓ ✓ ✓
Baseline demographic data are collected on the day of enrollment by study personnel through personal interview. Demographic factors of interest include age, race/ethnicity, educational attainment, marital status, occupation, work status, insurance type, household size and income and other housing-related factors. Demographics with potential for change over time are queried at each postpartum visit.
Baseline medical history is collected on the day of enrollment by study personnel through personal and medical record review. Characteristics surveyed include age at menarche, parity, interval from last pregnancy and obstetric history including prior complications like gestational diabetes, hypertensive disorders of pregnancy, prolonged bedrest and others. Medical chart review is performed to confirm or clarify aforementioned information and to retrieve information on medication use, pregnancy dating, and weight-related services such as nutrition consultations.
After delivery of the placenta, a 1x1cm segment of
For the subset of subjects who have Cesarean delivery for obstetric indications, and who consent, two 1x1 segments of
To quantify adipose deposition (visceral vs. subcutaneous) following maximal GWG [
At each of two study time points,
Additionally, the Pregnancy and Physical Activity Questionnaire (PPAQ) [
Extent of
Self-administered survey tools are used to assess psychological and cognitive/attitudinal variables at all study time points. Areas assessed include anxiety evaluated by the 20-item Spielberger State Anxiety Inventory(SSAI)) [
Sociocultural survey assessments are completed at each study time point and predominantly evaluate overall social support using the 20-item Medical Outcomes Study (MOS) social support survey [
Infant weights are measured in order to assess associations between maternal variables and infant weight. Infant weights are measured at all postpartum assessment time points when the infant is in attendance with maternal subjects, utilizing a Tanita BD-590 pediatric scale. Additionally, pediatrician records are obtained once each child reaches a year of life to capture length, weight and head circumference measurements for the offspring of each maternal participant from birth through one year.
To ensure the safety of participants who might be experiencing mood disorders, the EPDS is scored immediately after completion and before the participant leaves the study office. Participants scoring 12 or greater (suggestive of possible clinical depression) who score negative on the suicide question are encouraged to contact their provider to discuss symptoms. Participants scoring 12 or greater and with positive responses to the suicide question are considered at acute risk of injury or harm; an appropriately trained person performs a safety assessment and refers for immediate psychiatric evaluation if warranted.
The primary outcomes for this study are change in weight from pre-pregnancy to last measured prenatal weight prior to delivery (i.e. gestational weight gain or change) and change in weight from last measured prenatal weight to weight at 6 months post-partum (i.e. postpartum weight change). Additional weight measures are taken at each prenatal visit and at 6 weeks and 3 months postpartum. One of the main purposes of this study is to collect data related to these outcome as there is limited data in the literature thus we used standard deviation units as a way to determine a reasonable sample size. Assuming the definition of the primary outcomes from above and using a paired t-test for the main analysis with a two-tailed alpha = 0.05 and power = 0.80, we are able to detect a difference of as little as 0.30 standard deviation units with 100 patients. Adjusting for potential drop-out or missed data of 10%, we planned recruitment of 110 patients for either change in weight outcomes. To estimate detectable associations between predictors and either change in weight outcomes, we will use correlations since regression coefficients are essentially standardized correlations. So, for correlations between predictors and outcomes, we will have power = 0.80 to detect correlations of 0.28 with 100 patients in a regression model (as described below). In fact, because we will use multivariate regression models to partition the overall variance, we expect to have more power than estimated.
Descriptive statistics will be calculated in the usual way. To estimate the gestational weight change and the post-partum weight change, we will first calculate the change in weight as indicated above and use a standard paired t-test (if the weight change is normally distributed) or a Wilcoxon non-parametric test (if weight change is not normally distributed) to determine if there is a significant change in weight from pre-pregnancy to last prenatal visit preceding delivery weight and from this to six months postpartum. To determine the effect of the various predictors on these outcomes, we will use two approaches to model construction. First, we will use general linear models to model change in weight during gestation or change in weight post-partum, using the definitions for these outcomes from above. Second, we will use a mixed effects model to examine the individual trajectories of change over time, using all of the measures of weight throughout the gestation and post-partum periods. The predictors will be similar for the two analytic approaches, based on the conceptual model in Figure
Demographic characteristics of the study sample (n = 110) are presented in Table
28.3 5.1 28 24-32
32.5 1.8 32.6 31.4-33.7
Underweight 1 0.9 Normal 52 47.3 Overweight 32 29.1 Obese 25 22.7
White 63 67.7 Black/African American 7 7.5 Asian 5 5.4 Hawaiian/Pacific Islander 1 1.1 Other 11 11.8 Multiracial 6 6.5
Not Hispanic, Latino or Spanish 71 71.7 Hispanic, Latino or Spanish origin 28 28.3
24 24.2
16 15.5
75 69.4
In relationship with father of baby (n = 98) 92 93.9 Married (n = 99) 60 60.6
≤8th grade 2 2.0 >8th grade, < high school 3 3.0 High school graduate or GED 20 20.2 Trade or technical school after HS 5 5.1 Some college 25 25.3 4 year college degree 23 23.2 Other 21 21.2
Working full or part-time outside home 65 65.5 Homemaker 15 15.0
Great difficulty 12 12.0 Some difficulty 36 36.0 No difficulty 52 52.0
Resident practice 34 31.2 Faculty practice 75 68.9
Maternal and childhood obesity are significant public health issues that affect general immediate and long term health of women and children. Women receive more medical attention in pregnancy and the postpartum period than at any other healthful time in their lives; this time is ripe for intervention, especially as women are generally motivated to improve their health for benefit of their offspring. However, this is also a time of significant adaptations as it relates to physical, physiological, hormonal and behavioral changes (including sleep, diet, physical activity, smoking habits), new and different stressors, mood fluctuations, and changes in sociocultural identity and responses from the social environment, along with numerous other weight relevant factors. Excessive pregnancy weight gain and lack of postpartum weight loss [
This study is grounded in theory as conceptualized by women’s weight trajectories during both pregnancy and the post-partum period, and long-term maternal and child health and well-being, within a lifespan biopsychosocial framework. This study was designed to determine the feasibility of understanding multifactorial influences on maternal pregnancy and postpartum weight trajectories with the goal of gaining critical foundations of knowledge, experience and infrastructure on which to base future intervention research. Large trials recruiting socioeconomically and racially/ethnically diverse women are necessary to identify and analyze moderators and mediators of weight gain and loss as they relate to pregnancy and the postpartum period, and elucidate their effects on maternal and offspring health. We piloted critical variables that are relevant to future large scale studies addressing these issues.
The strengths of this study protocol are several. This is a longitudinal study design that includes a large number of variables and comprehensive assessments. Each of these critical factors individually and/or in aggregate examines different contexts of the biopsychosocial model. We were able to recruit a diverse population of women with 28% of our subjects being Latina, almost a quarter being non-US born and with approximately 15% from households speaking primary languages other than English. The study was able to recruit a socioeconomically diverse sample, as evidenced by their range of abilities to meet their household needs. This is critical for analysis of interactions amongst the biologic, psychologic, and social variables. The subject population represents women of childbearing age with more than half being overweight or obese in pregnancy [
A significant strength is the pilot nature of this study – performing a pilot acknowledges the importance of determining the feasibility of and acceptance of the design and overall burden to targeted participants. This is critical before embarking on a larger scale endeavor. However, our relatively modest sample size is a limitation. Adequately powering an intervention study with consideration of mediators and modifiers will require a larger sample size and is beyond the scope of this project. Generalizability of study findings may be limited by exclusion of non-English speakers, women with pre-existing physical and mental health conditions, adolescents, and women who did not seek care in early pregnancy.
Evidence of feasibility, acceptability, and consideration of weight influencing factors and behaviors other than diet and physical activity are essential to future epidemiological and intervention studies, including the design of new interventions that optimize appropriate maternal gestational weight gain and subsequent postpartum weight loss. We anticipate that the current study will produce valuable data and insights to help guide application of these findings to interventions targeting maternal health for maternal benefit but also for offspring benefit, thus promoting intergenerational health.
Body mass index
Developmental origins of health and disease
Edinburgh postnatal depression scale
Gestational weight gain
Health Insurance Portability and Accountability Act
Institute of Medicine
National Institute of Health
Pregnancy and postpartum observational determinants study
von Willebrand’s Factor
World Health Organization
The authors declare that they have no competing interests.
TMS, SC and MCR conceived of the study, made substantial contributions to conception and design of the study, drafted the manuscript, have been involved in revising the manuscript critically for important intellectual content. MML, BO, and BB have made substantial intellectual contributions to the conception and design of the study. NNZ made substantial contributions to the acquisition of data for this study and managed collection, processing, and analyses of biologic specimens. KL made substantial contributions to data acquisition, analyses and interpretation. All authors have been involved in reviewing the manuscript critically for important intellectual content, for revising and editing, and have given final approval of the version to be published.
Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR000161. Dr. Rosal also received funding from NIH/NIMHD (grant #1 P60 MD006912-02) and the CDC (grant # U48 DP001933). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors acknowledge the research staff involved in recruitment and retention activities (Laura Robidoux, Jodi Adams Puleo, Cassandra O’Connell), resident physicians whom facilitated data collection related to the delivery time point (Crina Boeras), and staff on whom we relied for administrative support for study activities (Sharon Smith, Gin-Fei Olendzki).